Accumulation of selected carotenoids, α-tocopherol and retinol in human ovarian carcinoma ascitic fluid

被引:15
|
作者
Schweigert, FJ
Raila, J
Sehouli, J
Buscher, U
机构
[1] Univ Potsdam, Inst Nutr Sci, Dept Physiol & Pathophysiol, DE-14558 Potsdam, Germany
[2] Charite, Dept Gynecol & Obstet, Berlin, Germany
[3] Charite, Dept Obstet, Berlin, Germany
关键词
retinol; alpha-tocopherol; carotenoids; cancer; ovarian carcinoma; plasma; ascites;
D O I
10.1159/000080457
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Patients with severe forms of cancer are reported to have reduced concentrations of micronutrients in plasma due to the chronic reduction of food intake and an increased metabolism of these components. The purpose of this study was to evaluate if an accumulation of carotenoids, alpha-tocopherol and retinol in malignant ascitic fluid in women with ovarian cancer might contribute to a loss of these components from plasma. Methods: Blood and ascitic fluid samples obtained from 21 women with ovarian carcinomas and 17 healthy controls were analyzed for retinol, retinol-binding protein (RBP), alpha-tocopherol and carotenoids. Results: Plasma concentrations of all micronutrients were lower in cancer patients compared to controls. Ascitic fluid concentration of all investigated components was comparable (73-110%) to plasma. While the mean concentration of retinol in malignant ascites represented 73% of that in plasma, the concentration of RBP was less than 10% resulting in an increased mean molar ratio of retinol to RBP from 1.18 to 10.5. Conclusions: The results suggest that lower plasma concentrations of micronutrients in women suffering from ovarian carcinoma are not only caused by a cachexia-induced decrease of food intake and a higher rate of metabolic utilization, but also by a substantial yet not considered transfer from plasma into ascitic fluid possibly associated with plasma lipoproteins. This raises questions with regard to the protective function of these plasma components in ascitic fluid, the consequences of paracentesis on an additional supplementation and finally the possibility to use one or a combination of these components as an additional marker to discriminate between benign and malignant ascites. Copyright (C) 2004 S. Karger AG, Basel.
引用
收藏
页码:241 / 245
页数:5
相关论文
共 50 条
  • [31] A RAPID AND SIMPLE METHOD FOR THE PURIFICATION OF TUMOR-CELLS FROM ASCITIC FLUID OF OVARIAN-CARCINOMA
    HIRTE, HW
    CLARK, DA
    MAZURKA, J
    OCONNELL, G
    RUSTHOVEN, J
    GYNECOLOGIC ONCOLOGY, 1992, 44 (03) : 223 - 226
  • [32] Human carcinoma-associated antigen (HCA), isolated from the endometrial carcinoma cell line KLE-1 and ascitic fluid of a patient with ovarian carcinoma; comparison with epiglycanin
    Thingstad, T
    Haavik, S
    Hansen, K
    Sletten, K
    Codington, JF
    Barsett, H
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 6 (02) : 121 - 129
  • [33] Human Ovarian Cancer-Derived Ascitic Fluid Has Mixed Effects on CRAds Efficacy
    Lopez, Veronica M.
    Cuneo, Nicasio
    Gangemi, Mariela A.
    Sganga, Leonardo
    Demonte, Marina
    Soderini, Alejandro
    Podhajcer, Osvaldo L.
    MOLECULAR THERAPY, 2013, 21 : S242 - S243
  • [34] ASCITIC FLUID FROM HUMAN OVARIAN-CANCER PATIENTS CONTAINS GROWTH-FACTORS NECESSARY FOR INTRAPERITONEAL GROWTH OF HUMAN OVARIAN ADENOCARCINOMA CELLS
    MILLS, GB
    MAY, C
    HILL, M
    CAMPBELL, S
    SHAW, P
    MARKS, A
    JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (03): : 851 - 855
  • [35] Cytological features of small cell carcinoma of the ovary-hypercalcemic type/malignant ovarian rhabdoid tumor in ascitic fluid
    Lae, Marick
    Bourgoin, Remi
    Cornelis, Francoise
    Klijanienko, Jerzy
    DIAGNOSTIC CYTOPATHOLOGY, 2018, 46 (04) : 365 - +
  • [36] THE STUDY OF ANTIBODIES AND ANTIGENS DISSOCIATED FROM THE IMMUNE-COMPLEXES EXTRACTED FROM OVARIAN-CARCINOMA ASCITIC FLUID
    QIAN, H
    FENG, J
    FU, TY
    GYNECOLOGIC ONCOLOGY, 1985, 20 (01) : 100 - 108
  • [37] Establishment of Primary Cell Culture From Ascitic Fluid and Solid Tumor Obtained From Epithelial Ovarian Carcinoma Patients
    Kar, Rajarshi
    Chawla, Diwesh
    Gupta, Bindiya
    Mehndiratta, Mohit
    Wadhwa, Neelam
    Agarwal, Rachna
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 (09) : 2000 - 2005
  • [38] Interferon gamma anti-tumor activity in human ovarian carcinoma cell lines and in primary cultures of ascitic cells from human ovarian cancer
    Wall, L
    Burke, F
    Smyth, JF
    Balkwill, FR
    BRITISH JOURNAL OF CANCER, 1999, 80 : 84 - 84
  • [39] PHENOTYPIC CHARACTERISTICS OF MONONUCLEAR-CELLS IN HUMAN OVARIAN-TUMORS - WITH SPECIAL REFERENCE TO CYSTIC AND ASCITIC FLUID
    KULLANDER, S
    RAUSING, A
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1994, 4 (05) : 298 - 305
  • [40] Cytotoxicity, accumulation, and efflux of cisplatin and its metabolites in human ovarian carcinoma cells
    Shirazi, FH
    Molepo, JM
    Stewart, DJ
    Ng, CE
    Raaphorst, GP
    Goel, R
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 1996, 140 (02) : 211 - 218